Literature DB >> 8487777

Recombinant Fel d.I: Expression, purification, IgE binding and reaction with cat-allergic human T cells.

B L Rogers1, J P Morgenstern, R D Garman, J F Bond, M C Kuo.   

Abstract

This study describes the properties of the two recombinantly expressed polypeptide chains of Fel d I, the major allergen produced by the domestic cat (Felis domesticus). An inframe linker encoding polyhistidine has been added to the 5' ends of the Fel d I chains 1 and 2 cDNAs to facilitate purification using Ni2+ ion affinity chromatography. This method provides high yields in a single step of rchain 1 and rchain 2 of Fel d I with a > 90% level of purity. Polymerase chain reaction (PCR) methods were used to introduce a thrombin cleavage site (LVPR decreases GS) at the N-terminus of both chains. Thrombin cleavage of rchain 1 and rchain 2 followed by HPLC purification of the cleavage products allowed the isolation of each recombinant chain with only two additional residuals (GS) at the N-terminus of the native sequence. Amino acid sequencing analysis of the N-terminus and mass spectrometry of these polypeptides demonstrated that they are highly pure and full-length. Direct ELISA assays showed that IgE from cat-allergic patients binds to both rchain 1 and rchain 2 of Fel d I, demonstrating that both these chains contribute to the allergenicity of this heterodimeric protein. An examination of the reactivity of T cells derived from cat-allergic patients revealed that both polypeptide chains contribute to the T cell response to this allergen. Consequently, it is concluded that the immunological response to Fel d I is composed of a reaction at both the B and T cell level to each of the two chains that constitute the native allergen.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8487777     DOI: 10.1016/0161-5890(93)90030-f

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  7 in total

Review 1.  Recombinant allergens.

Authors:  C Grégoire; M D Chapman
Journal:  Clin Rev Allergy Immunol       Date:  2001-10       Impact factor: 8.667

Review 2.  Molecular characterization of allergens.

Authors:  S S Mohapatra; R F Lockey
Journal:  Clin Rev Allergy Immunol       Date:  2001-10       Impact factor: 8.667

3.  The major dog allergens, Can f 1 and Can f 2, are salivary lipocalin proteins: cloning and immunological characterization of the recombinant forms.

Authors:  A Konieczny; J P Morgenstern; C B Bizinkauskas; C H Lilley; A W Brauer; J F Bond; R C Aalberse; B P Wallner; M T Kasaian
Journal:  Immunology       Date:  1997-12       Impact factor: 7.397

4.  Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I.

Authors:  T J Briner; M C Kuo; K M Keating; B L Rogers; J L Greenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

5.  Glutaraldehyde-Modified Recombinant Fel d 1: A Hypoallergen With Negligible Biological Activity But Retained Immunogenicity.

Authors:  Serge A Versteeg; Ingrid Bulder; Martin Himly; Toni M van Capel; R van den Hout; Stef J Koppelman; Esther C de Jong; Fatima Ferreira; Ronald van Ree
Journal:  World Allergy Organ J       Date:  2011-07-14       Impact factor: 4.084

6.  Mouse Model of Cat Allergic Rhinitis and Intranasal Liposome-Adjuvanted Refined Fel d 1 Vaccine.

Authors:  Natt Tasaniyananda; Urai Chaisri; Anchalee Tungtrongchitr; Wanpen Chaicumpa; Nitat Sookrung
Journal:  PLoS One       Date:  2016-03-08       Impact factor: 3.240

7.  Keep the cat, change the care pathway: A transformational approach to managing Fel d 1, the major cat allergen.

Authors:  Ebenezer Satyaraj; Harold James Wedner; Jean Bousquet
Journal:  Allergy       Date:  2019-10       Impact factor: 13.146

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.